Tage Ramakrishna, MD
Progenics Pharmaceuticals, Inc.
19
0
19
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+3 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (19)
Showing 10 of 19 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Taisho Director
Taisho Pharmaceutical Co., Ltd.
Shared therapeutic areas:
Thomas Marbury, MD
Orlando Clinical Research Center
Shared therapeutic areas:
Paolo Bonato, PhD
Spaulding Rehabilitation Hospital
Shared therapeutic areas:
Herbert B Slade, MD
Healthpoint
Shared therapeutic areas:
Pablo Tebas, MD
University of Pennsylvania
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
James C Eisenach, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Suman Wason, MD
Lexicon Pharmaceuticals, Inc.
Shared therapeutic areas:
Suman Sheraz, PhD*
Riphah International University
Shared therapeutic areas:
Neal S Young, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (19)
Showing 19 of 19 trials
A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients
Study of Methylnaltrexone (MNTX) for the Relief of Constipation
Effect of Methylnaltrexone (MNTX) on Electrocardiogram (ECG) Parameters and Cardiac Repolarization
Evaluate the Pharmacokinetics (PK) of Methylnaltrexone (MNTX) in Healthy Adult Subjects
Tolerance and Pharmacokinetics Study of MNTX Tablets
Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets
Study of Pharmacokinetics, Safety and Tolerability of Intravenous Methylnaltrexone Bromide
Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX
Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX
Pharmacokinetics and Bioavailability of Single Subcutaneous Doses of Methylnaltrexone Versus Intravenous Dose
Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Subjects With Impaired Renal Function
Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function
Effects of MNTX on CYP450 2D6 in Metabolizers of Dextromethorphan
Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus
Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function
Methylnaltrexone in Patients With Opioid-Induced Bowel Dysfunction
Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone
All 19 trials loaded